Skip to main content
. 2016 Aug 31;7(39):64300–64308. doi: 10.18632/oncotarget.11734

Figure 2. CD8+ infiltrate.

Figure 2

CD8+ of at least 1% was seen in 6/20 (30.0%) nerves, 45/68 (66.2%) benign lesions and 30/53 (56.6%) of MPNST. CD8+ of at least 5% was seen in 1/20 (5.0%) nerves, 14/68 (20.6%) benign lesions and 11/53 (20.7%) of MPNST. There was no difference between benign and malignant tumors at the 5% (p=0.282) or 1% (p=0.982) expression threshold.